Niki BioSolutions, Inc. Accretion Expense
Niki BioSolutions, Inc. (NIKI) reported Accretion Expense of $1.44 thousand for the 12-month period ending 2022-12-31, per its 6-K filed 2025-10-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2025-10-08
| Period end | Accretion Expense 6 month | Accretion Expense 12 month |
|---|---|---|
| 2022-12-31 | $1.44K 6-K · filed 2025-10-08 | |
| 2022-06-30 | $1.10K 6-K · filed 2023-12-22 | |
| 2018-12-31 | $691.10K 20-F · filed 2019-04-15 |